Related references
Note: Only part of the references are listed.Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies
Eskandar Taghizadeh et al.
IUBMB LIFE (2019)
Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A review
Eskandar Taghizadeh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages
Maija Ruuth et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approach
Ilenia Minicocci et al.
ATHEROSCLEROSIS (2015)
Genetic linkage analysis in the age of whole-genome sequencing
Jurg Ott et al.
NATURE REVIEWS GENETICS (2015)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Nishant Agrawal et al.
SCIENCE (2011)
Exome sequencing: the sweet spot before whole genomes
Jamie K. Teer et al.
HUMAN MOLECULAR GENETICS (2010)
Functional Variant Disrupts Insulin Induction of USF1 Mechanism for USF1-Associated Dyslipidemias
Jussi Naukkarinen et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
A Systems Genetics Approach Implicates USF1, FADS3, and Other Causal Candidate Genes for Familial Combined Hyperlipidemia
Christopher L. Plaisier et al.
PLOS GENETICS (2009)
Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders
Alvaro Rada-Iglesias et al.
GENOME RESEARCH (2008)
USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier
Suming Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
USF1 contributes to high serum lipid levels in Dutch FCHL families and US whites with coronary artery disease
Jenny C. Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia
Gerly M. van der Vleuten et al.
JOURNAL OF LIPID RESEARCH (2007)
Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions
Konstantinos Kantartzis et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Upstream stimulating factors: highly versatile stress-responsive transcription factors
S Corre et al.
PIGMENT CELL RESEARCH (2005)
USF1 and dyslipidemias: converging evidence for a functional intronic variant
J Naukkarinen et al.
HUMAN MOLECULAR GENETICS (2005)
Genetics of familial combined hyperlipidemia and risk of coronary heart disease
CC Shoulders et al.
HUMAN MOLECULAR GENETICS (2004)
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)
P Pajukanta et al.
NATURE GENETICS (2004)
Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families
A Huertas-Vázquez et al.
ANNALS OF HUMAN GENETICS (2004)
Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study
MJ Veerkamp et al.
CIRCULATION (2004)
Genetic dissection of familial combined hyperlipidemia
PMH Eurlings et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III-IV locus - The NHLBI Family Heart Study
H Coon et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families
WD Pei et al.
CLINICAL GENETICS (2000)
Share Paper
